Isomorphic Labs Raises $5 Billion for AI Drug Design

Share

Isomorphic Labs raised $5 billion in a Series C funding round. The round was co-led by Greenoaks and Sequoia. The company is preparing its first therapeutic programs for clinical trials. Alphabet invested again in the startup focused on AI drug design.

Source: Read the original article

Disclaimer: this content is for information purposes only and is not financial advice. Cryptocurrencies are highly volatile: you may lose all of your capital. Always do your own research. Legal notice
Telemac
Telemachttp://cryptoinfo.ch
Passionné de nouvelles technologies, j’explore l’univers de la blockchain et des cryptomonnaies pour partager l’actualité et les innovations du secteur.

Read More

Items